Market Closed -
Japan Exchange
07:00:00 17/05/2024 BST
5-day change
1st Jan Change
5,270
JPY
-0.57%
-0.38%
+2.53%
Tranche Update on Noevir Holdings Co., Ltd.'s Equity Buyback Plan announced on November 7, 2017.
November 09, 2017 at 02:00 am
From November 7, 2017 to November 9, 2017, the company has repurchased 1,295,000 shares, representing 3.65% for ¥9,971.5 million. With this, the company has completed the repurchase of 1,295,000 shares, representing 3.65% for ¥9,971.5 million under the buyback announced on November 7, 2017.
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending September 30, 2024
05-09
CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending September 30, 2024
11-07
CI
Noevir Holdings Co., Ltd. Announces Dividend for the Fiscal Year Ended September 30, 2023, Payable on December 11, 2023
11-07
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2024
11-07
CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending September 30, 2023
07/08/23
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2024
07/08/23
CI
Noevir Holdings Co., Ltd. Reports Earnings Results for the Half Year Ended March 31, 2023
10/05/23
CI
Noevir Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending September 30, 2023
10/05/23
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2023
10/05/23
CI
Noevir Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending September 30, 2023
07/02/23
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending March 2023 and for the Fiscal Year Ending September 30, 2023
07/02/23
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending March 2023 and for the Fiscal Year Ending September 30, 2023
10/11/22
CI
Noevir Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending September 30, 2023
10/11/22
CI
Noevir Holdings Co., Ltd. Announces Year-End Dividend for the Fiscal Year Ended September 30, 2022, Payable on December 09, 2022
10/11/22
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending September 2022
04/08/22
CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 30, 2022
04/08/22
CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 2022
11/05/22
CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending September 2022
11/05/22
CI
Noevir Holdings Co., Ltd. Provides Earnings Guidance for the Six Months Ending March 2022 and for the Year Ending September 2022
08/02/22
CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 2022
08/02/22
CI
FACTBOX-Japanese companies opening COVID-19 vaccination sites amid slow national rollout
04/06/21
RE
An unknown buyer acquired a 12.9% stake in Noevir Holdings Co., Ltd. from Takashi Okura.
02/08/20
CI
Noevir Holdings Co., Ltd. Announces Distribution
18/11/19
CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 30, 2019
13/08/19
CI
Noevir Holdings Co., Ltd. Announces Consolidated Earnings Results for the Nine Months Ended June 30, 2019; Provides Earnings Guidance for the Fiscal Year Ending September 30, 2019
13/08/19
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Noevir Holdings Co., Ltd. is a Japan-based company engaged in the manufacture and sale of cosmetics, toiletries, pharmaceuticals and foods, as well as the purchase and sale of cosmetic products. The Company operates in three business segments. The Cosmetics segment is engaged in the manufacture and sale of cosmetics and toiletries, as well as the purchase and sale of cosmetic products. The Pharmaceuticals and Foods segment is engaged in the manufacture and sale of general drugs and foods. The Others segment is engaged in the purchase and sale of apparels, body fashion, aircrafts and vessels, as well as air transportation business.
More about the company
Last Close Price
5,270
JPY
Average target price
5,730
JPY
Spread / Average Target
+8.73%
Consensus
1st Jan change
Capi.
+2.53% 1.17B -0.68% 264B +19.72% 20.89B 0.00% 19.67B +15.62% 12.52B -14.17% 9.53B +19.93% 8.03B +10.20% 6.01B -2.43% 4.49B -13.55% 4.01B
Cosmetics & Perfumes
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
NOEVIR HOLDINGS CO., LTD. 
